SI
PRAH

Stephens Inc’s PRA Health Sciences, Inc. PRAH Stock Holding History

Stephens Inc’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-79
Closed -$13K – 1420
2021
Q2 		$13K Sell
79
-41
-34% -$6.84K ﹤0.01% 1329
2021
Q1 		$18K Buy
120
+2
+2% +$272 ﹤0.01% 1287
2020
Q4 		$15K Hold
118
– – ﹤0.01% 1200
2020
Q3 		$12K Buy
118
+94
+392% +$9.58K ﹤0.01% 1167
2020
Q2 		$2K Sell
24
-31
-56% -$2.88K ﹤0.01% 1143
2020
Q1 		$5K Sell
55
-67
-55% -$6.53K ﹤0.01% 1093
2019
Q4 		$14K Hold
122
– – ﹤0.01% 1130
2019
Q3 		$12K Buy
122
+17
+16% +$1.69K ﹤0.01% 1137
2019
Q2 		$10K Buy
105
+12
+13% +$1.15K ﹤0.01% 1167
2019
Q1 		$10K Buy
93
+15
+19% +$1.57K ﹤0.01% 1162
2018
Q4 		$7K Buy
78
+37
+90% +$3.74K ﹤0.01% 1097
2018
Q3 		$5K Buy
+41
New +$4.27K ﹤0.01% 1153

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Stephens Inc's PRAH Position: Q3 2021 in Review

Stephens Inc sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 79 shares — an estimated $13K sold.

Stephens Inc first reported a position in PRAH in Q3 2018 and held it in 12 quarters. The position peaked at $18K in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Stephens Inc reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Stephens Inc sold 79 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $13K.
  • Stephens Inc first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 12 quarters.
  • Stephens Inc's PRA Health Sciences, Inc. position peaked at $18K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Stephens Inc's 13F filing for Q3 2021, filed 27 Oct 2021.